OPTOMED OY A      EO 0,05
OPTOMED OY A EO 0,05
Share · FI4000410881 · A2PWGR (XHEL)
Overview
No Price
Closing Price XHEL 30.01.2026: 3,94 EUR
30.01.2026 16:29
Current Prices from OPTOMED OY A EO 0,05
ExchangeTickerCurrencyLast TradePriceDaily Change
XHEL: NASDAQ HELSINKI LTD
NASDAQ HELSINKI LTD
OPTOMED.HE
EUR
30.01.2026 16:29
3,94 EUR
0,13 EUR
+3,41 %
XFRA: Frankfurt
Frankfurt
36U0.F
EUR
30.01.2026 07:20
3,77 EUR
-0,19 EUR
-4,68 %
XDQU: Quotrix
Quotrix
OOYRSC81.DUSD
EUR
30.01.2026 06:27
3,82 EUR
-0,14 EUR
-3,42 %
XDUS: Düsseldorf
Düsseldorf
OOYRSC81.DUSB
EUR
29.01.2026 07:12
3,95 EUR
0,32 EUR
+8,98 %
Share Float & Liquidity
Free Float 69,83 %
Shares Float 14,97 M
Shares Outstanding 21,43 M
Company Profile for OPTOMED OY A EO 0,05 Share
Optomed Oyj, a medical technology company, manufactures and sells handheld fundus cameras and screening software in Finland, China, and internationally. The company operates through two segments, Devices and Software segments. The company develops, manufactures, and sells fundus camera products, which are used by ophthalmologists, pediatricians, endocrinologists, neurologists, and primary care professionals. It offers camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Polaris, and Optomed Halo brands, as well as OEM cameras, including Pictor Plus, Pictor Prestige, Visuscout 100, Fundus Module 300, and Signal brand names. The company also provides Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases, such as diabetic retinopathy; Avenue Archive, an application software for displaying, archiving, and transmitting healthcare information; Avenue Telemedicine, a telemedicine solution for remote image analysis; Avenue AI, an automated diabetic retinopathy screening service; and Avenue Sync, a software solution for integrating fundus camera to the hospital image archive and worklist server. In addition, it offers Avenue Cancer Screen, a screening process management software for breast, cervical, and colorectal cancer; Optomed RIS, a software solution for healthcare imaging units for enhancing the diagnostic process and treatment decisions; Sectra PACS, a modular system optimized for use by high production healthcare providers; Optomed Service Portal, a support function for healthcare units that order and produce imaging services; Facad, a tracing software for visible light imaging and cephalometric measurements; and Sectra PACS Pathology, a digital pathology solution, which allows scanned glass slides to be distributed and diagnosed. Further, the company provides professional IT consulting services for government institutions. It sells its products and solutions through OEMs, distributors, and direct sales. The company's customers include hospitals, eye clinics, and optician chains and stores. The company was incorporated in 2004 and is headquartered in Oulu, Finland.
AI Analysis of OPTOMED OY A EO 0,05
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of OPTOMED OY A EO 0,05
No AI threads available for this company yet.

Company Data

Name OPTOMED OY A EO 0,05
Company Optomed Oyj
Website https://www.optomed.com
Primary Exchange XHEL Frankfurt
WKN A2PWGR
ISIN FI4000410881
Asset Class Share
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO Juho Himberg
Market Capitalization 84 Mio
Country Finland
Currency EUR
Employees 0,1 T
Address Yrttipellontie 1, 90230 Oulu
IPO Date 2019-12-05

Ticker Symbols

Name Symbol
NASDAQ HELSINKI LTD OPTOMED.HE
Düsseldorf OOYRSC81.DUSB
Frankfurt 36U0.F
Quotrix OOYRSC81.DUSD
More Shares
Investors who hold OPTOMED OY A EO 0,05 also have the following shares in their portfolio:
American Funds AMCAP Fund Class C
American Funds AMCAP Fund Class C Fund
CAPITAL ONE FINL 17/22FLR
CAPITAL ONE FINL 17/22FLR Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026